Basit öğe kaydını göster

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.

dc.contributor.authorKöstek, Osman
dc.contributor.authorSelam, Meltem
dc.contributor.authorTanrıverdi, Özgür
dc.contributor.authorPaydaş, Semra
dc.contributor.authorUrakçı, Zuhat
dc.contributor.authorAtağ, Elif
dc.contributor.authorGüncan, Sabri
dc.contributor.authorÜrün, Yüksel
dc.contributor.authorAlkan, Ali
dc.contributor.authorKaya, Ali Osman
dc.contributor.authorÖzyükseler, Deniz Tataroğlu
dc.contributor.authorTaşkaynatan, Halil
dc.contributor.authorYıldırım, Mustafa
dc.contributor.authorSönmez, Müge
dc.contributor.authorBaşoğlu, Tuğba
dc.contributor.authorGündüz, Şeyda
dc.contributor.authorKılıçkap, Saadettin
dc.contributor.authorTural, Deniz
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorSümbül, Ahmet Taner
dc.contributor.authorArtaç, Mehmet
dc.contributor.authorÖzhan, Nail
dc.contributor.authorAkar, Emre
dc.contributor.authorÇakar, Burcu
dc.contributor.authorEkenel, Meltem
dc.contributor.authorErman, Mustafa
dc.contributor.authorCoşkun, Hasan Şenol
dc.contributor.authorSelçukbiricik, Fatih
dc.contributor.authorKeskin, Özge
dc.contributor.authorTürköz, Fatma Paksoy
dc.contributor.authorOruç, Kerem
dc.contributor.authorBayram, Selami
dc.contributor.authorYılmaz, Uğur
dc.contributor.authorBilgetekin, İrem
dc.contributor.authorYıldız, Birol
dc.contributor.authorŞendur, Mehmet Ali Nahit
dc.contributor.authorPaksoy, Nail
dc.contributor.authorDirican, Ahmet
dc.contributor.authorErdem, Dilek
dc.date.accessioned2021-03-02T16:48:01Z
dc.date.available2021-03-02T16:48:01Z
dc.identifier.citationTural D., Ölmez Ö. F. , Sümbül A. T. , Artaç M., Özhan N., Akar E., Çakar B., Köstek O., Ekenel M., Erman M., et al., "Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.", European urology focus, 2020
dc.identifier.issn2405-4569
dc.identifier.otherav_193c1701-ea07-4697-9c71-3ce1ad4724fa
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3343
dc.identifier.urihttps://doi.org/10.1016/j.euf.2020.09.010
dc.language.isoeng
dc.titleAtezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
dc.typeMakale
dc.relation.journalEuropean urology focus
dc.contributor.department, ,
dc.contributor.firstauthorID2495627


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster